SBC Medical Group (NASDAQ:SBC) Upgraded to “Strong-Buy” at Wall Street Zen

Wall Street Zen upgraded shares of SBC Medical Group (NASDAQ:SBC) from a buy rating to a strong-buy rating in a research note issued to investors on Monday morning,Wall Street Zen reports.

SBC has been the topic of a number of other research reports. Weiss Ratings upgraded shares of SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, September 22nd. BTIG Research restated a “buy” rating and issued a $8.00 price objective on shares of SBC Medical Group in a report on Thursday, August 13th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $8.50.

SBC Medical Group Price Performance

SBC opened at $5.34 on Monday. The stock has a 50-day moving average price of $4.09 and a 200-day moving average price of $3.63. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The firm has a market cap of $549.22 million, a PE ratio of 11.36, a P/E/G ratio of 2.29 and a beta of 0.56. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.37.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). The firm had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. Sell-side analysts predict that SBC Medical Group will post 0.44 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SBC Medical Group

Hedge funds have recently bought and sold shares of the business. State Street Corp boosted its holdings in shares of SBC Medical Group by 59.7% during the 2nd quarter. State Street Corp now owns 49,239 shares of the company’s stock valued at $152,000 after acquiring an additional 18,400 shares during the last quarter. Citadel Advisors LLC purchased a new position in shares of SBC Medical Group during the second quarter valued at approximately $446,000. Two Sigma Securities LLC purchased a new position in shares of SBC Medical Group during the second quarter valued at approximately $66,000. Bank of America Corp DE bought a new position in SBC Medical Group during the second quarter valued at approximately $35,000. Finally, BlackRock Inc. bought a new position in SBC Medical Group during the second quarter valued at approximately $2,846,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.

About SBC Medical Group

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.